Bioton acquires 50.11% stake in Biolek - MarketLine Financial Deals

Bioton acquires 50.11% stake in Biolek

Bioton acquires 50.11% stake in Biolek - MarketLine Financial Deals
Bioton acquires 50.11% stake in Biolek
Published Sep 01, 2011
2 pages — Published Sep 01, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BIOTON S.A., a Poland-based biotechnology company, has acquired a 50.11% stake in BIOLEK.

  
Source:
Document ID
MA78366_110905
Country
Ticker
BIO=PL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Bioton acquires 50.11% stake in Biolek" Sep 01, 2011. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Bioton-acquires-50-11-stake-in-Biolek-2052-68375>
  
APA:
MarketLine Financial Deals. (2011). Bioton acquires 50.11% stake in Biolek Sep 01, 2011. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Bioton-acquires-50-11-stake-in-Biolek-2052-68375>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.